Warsaw - Delayed Quote PLN

Krka, d. d. (KRK.WA)

Compare
660.00
0.00
(0.00%)
At close: January 28 at 4:33:31 PM GMT+1

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in PLN.
NameTitlePayExercisedYear Born
Dr. Jože Colaric President of Management Board & CEO 1.38M -- 1955
Dr. Ales Rotar Ph.D. Member of the Management Board and Director of Pharmaceutical R&D & Production 990k -- 1960
Mr. David Bratoz Member of the Management Board 812k -- 1976
Dr. Vinko Zupancic Ph.D. Director of API R&D, Production & Supply Chain and Member of the Management Board 828k -- 1971
Ms. Milena Kastelic Member of the Mgt. Board, Worker Director & Deputy Dir. of Pharmaceutical Production 303k -- 1968
Mr. Brane Kastelec M.S., MSc Director of Finance -- -- --
Matej Baselj Technical Director -- -- --
Mr. Borut Lekše Deputy CEO of Legal Affairs & Head of Legal Affairs -- -- --
Teja Lesjak Head of Public Relations -- -- --
Ms. Elizabeta Suhadolc Director of Marketing & Pharmaceuticals -- -- --

Krka, d. d.

Šmarješka cesta 6
Novo Mesto, 8501
Slovenia
386 7 331 2111 https://www.krka.si
Sector: 
Healthcare
Full Time Employees: 
12,675

Description

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company also provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising analgesics antimicrobials, antiparasitics, disinfectants, vitamins, and minerals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.

Corporate Governance

Krka, d. d.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 30, 2025 at 10:59 AM UTC

Krka, d. d. Earnings Date

Recent Events

July 23, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers